David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
iHeartMedia
IHRT
$415M
| $249K | ﹤0.01% |
141,512
-60,427
| -30% | -$80.5K |
|
3852
First Trust Financials AlphaDEX Fund
FXO
$1.13B
| $249K | ﹤0.01% |
4,436
-300
| -6% | -$15.7K |
|
3853
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.12B
| $248K | ﹤0.01% |
+2,218
| New | +$229K |
|
3854
iShares US Healthcare ETF
IYH
$3.82B
| $247K | ﹤0.01% |
+4,370
| New | +$246K |
|
3855
State Street SPDR S&P Software & Services ETF
XSW
$511M
| $245K | ﹤0.01% |
1,289
| – | – |
|
3856
La-Z-Boy
LZB
$1.29B
| $245K | ﹤0.01% |
6,582
-157,670
| -96% | -$6.3M |
|
3857
PUT
Bilibili
BILI
$6.91B
| $245K | ﹤0.01% |
11,400
-48,800
| -81% | -$898K |
|
3858
FTAI Infrastructure
FIP
$443M
| $244K | ﹤0.01% |
+39,560
| New | +$200K |
|
3859
Brink's
BCO
$4.65B
| $243K | ﹤0.01% |
2,724
-25,904
| -90% | -$2.25M |
|
3860
PUT
Charles River Laboratories
CRL
$14.3B
| $243K | ﹤0.01% |
1,600
| – | – |
|
3861
Dimensional US Real Estate ETF
DFAR
$1.79B
| $242K | ﹤0.01% |
10,336
-4,024
| -28% | -$93.4K |
|
3862
Mercury Insurance
MCY
$5.89B
| $242K | ﹤0.01% |
+3,600
| New | +$214K |
|
3863
Franklin FTSE United Kingdom ETF
FLGB
$933M
| $242K | ﹤0.01% |
7,911
-1,594
| -17% | -$47.1K |
|
3864
Editas Medicine
EDIT
$461M
| $242K | ﹤0.01% |
110,113
-349,587
| -76% | -$572K |
|
|
APLS
3865
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $241K | ﹤0.01% |
13,900
-4,300
| -24% | -$79.6K |
|
3866
Portland General Electric
POR
$5.85B
| $240K | ﹤0.01% |
5,911
-20,075
| -77% | -$842K |
|
3867
Limbach Holdings
LMB
$497M
| $239K | ﹤0.01% |
+1,708
| New | +$194K |
|
|
COOP
3868
CALL
DELISTED
Mr. Cooper
COOP
| $239K | ﹤0.01% |
1,600
-8,200
| -84% | -$1.05M |
|
3869
CALL
Starwood Property Trust
STWD
$6.03B
| $237K | ﹤0.01% |
11,800
-23,200
| -66% | -$451K |
|
3870
CALL
Westlake Corp
WLK
$9.78B
| $235K | ﹤0.01% |
+3,100
| New | +$254K |
|
|
EOSEW
3871
Eos Energy Enterprises Warrant
EOSEW
$27.2M
| $235K | ﹤0.01% |
499,827
| – | – |
|
3872
CALL
Medifast
MED
$134M
| $235K | ﹤0.01% |
+16,700
| New | +$219K |
|
3873
Corsair Gaming
CRSR
$1.18B
| $234K | ﹤0.01% |
24,827
-1,106
| -4% | -$8.92K |
|
|
LOVE
3874
LoveSac
LOVE
$232M
| $234K | ﹤0.01% |
+12,857
| New | +$244K |
|
3875
CALL
ATI
ATI
$28.6B
| $233K | ﹤0.01% |
+2,700
| New | +$185K |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.